ARUP's Laboratory Test Directory

Cystic Fibrosis (CFTR) 5T Mutation : 0056003

Mnemonic: IVS-8

Methodology: Polymerase Chain Reaction/Fragment Analysis
Performed: Sun-Sat
Reported: 3-7 days
Specimen Required: Collect: One 3 mL lavender (EDTA), pink (K2EDTA) or yellow (ACD solution A or B).

Storage/Transport Temperature: 3 mL whole blood at 2-8°C. (Min: 1 mL)

Stability (collection to initiation of testing): Ambient: 3 days; Refrigerated: 5 days; Frozen: Unacceptable
Interpretive Data: Background Information for Cystic Fibrosis (CFTR) 5T Mutation
Characteristics:
The 5T mutation is a mild cystic fibrosis transmembrane regulator (CFTR) mutation resulting in improper mRNA splicing removing exon 9 from 90 percent of the CFTR protein. It is commonly observed in combination with a severe mutation on the other allele in individuals with a single CF symptom such as congenital bilateral absence of the vas deferens, bronchiectasis, or idiopathic pancreatitis.
Allele Frequency:
5 percent.
Penetrance:
Variable
Cause:
5T residues in the eighth CFTR intron instead of the more common seven.
Mutation tested:
5T mutation in CFTR.
Methodology:
Polymerase chain reaction, oligonucleotide ligation assay (OLA), fluorescent hybridization probes, and capillary electrophoresis.
Analytical Sensitivity and Specificity:
99 percent.
Limitations:
Mutations within the primer/probe regions could affect the analytical sensitivity of this assay



Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Please refer to Statement C in the Compliance Statements section in the front of the Laboratory Test Directory.
CPT Code(s): 83891 Isolation; 83900 Multiplex amplification; 83901 x31 Additional amplification; 83914 x2 OLA;  83909 Capillary electrophoresis; 83912 Interpretation and report
 
 

 

 

 
All ARUP Sites:        www.aruplab.com     ·     www.arupconsult.com     ·     www.arup.utah.edu     ·     www.childx.org     ·     www.utahblood.org